Why lab work comes before everything else
Testosterone replacement therapy is not a supplement you add to your routine. It is a clinician-supervised hormonal intervention that affects red blood cell production, cardiovascular function, prostate tissue, liver metabolism, and fertility. Done right, it can meaningfully improve quality of life for men with confirmed low testosterone. Done carelessly, it can create new problems while masking others.
The required labs serve three purposes: confirming that low testosterone is actually the issue, identifying contraindications before they become harm, and establishing a baseline so clinicians can detect changes — good or bad — once therapy begins.
What labs are required before starting TRT?
| Lab test | Why it’s ordered | Required for all? |
|---|---|---|
| Total testosterone (×2 morning) | Confirms deficiency on two separate AM draws; pulsatile secretion makes a single draw insufficient | Yes |
| Free testosterone / SHBG | Identifies men with low bioavailable testosterone despite borderline total T | Yes |
| LH and FSH | Distinguishes primary (testicular) from secondary (pituitary) hypogonadism; rules out pituitary adenoma | Yes |
| Estradiol (E2) | Baseline before therapy; monitors aromatization during treatment | Yes |
| CBC / hematocrit | Baseline for erythrocytosis monitoring; TRT raises red blood cell production | Yes |
| PSA | Required for men over 40; establishes baseline before androgen exposure | Men 40+ |
| Comprehensive metabolic panel (CMP) | Liver function, kidney function, glucose, and electrolytes at baseline | Yes |
| Prolactin | Rules out prolactinoma when LH/FSH are low; ordered when clinical picture suggests central cause | When indicated |
Total testosterone (two morning draws)
This is the central diagnostic value. Because testosterone follows a strong circadian rhythm, peaking between 7 and 10 AM and declining through the day, specimens must be collected in the early morning. A single reading is not sufficient — the Endocrine Society guidelines require two separate morning values below the reference threshold, on different days, to confirm deficiency. Both the numbers and the timing of collection are documented.
Free testosterone and SHBG
Total testosterone includes bound and unbound fractions. The biologically active portion is free testosterone — the fraction not bound to sex hormone-binding globulin (SHBG) or albumin. A man with total testosterone at 350 ng/dL and very high SHBG may have free testosterone consistent with significant deficiency. Measuring SHBG lets the clinician calculate or directly measure the free fraction, giving a more accurate picture of androgen availability at the tissue level.
LH and FSH (gonadotropins)
Luteinizing hormone (LH) and follicle-stimulating hormone (FSH) tell the clinician where the problem originates. Low testosterone with low or normal LH and FSH points to a pituitary or hypothalamic issue (secondary hypogonadism) — which may indicate a pituitary adenoma that needs imaging, not simply TRT. Low testosterone with appropriately elevated LH and FSH points to primary testicular failure. The distinction matters for both treatment planning and for ruling out serious underlying pathology.
Estradiol (E2)
Testosterone aromatizes to estradiol in peripheral tissues. Clinicians check baseline estradiol before starting TRT and monitor it during therapy because excessive estrogen conversion causes side effects including fluid retention, gynecomastia, and mood changes. Estradiol baseline also informs whether an aromatase inhibitor may be needed during therapy.
Complete blood count (CBC) and hematocrit
Testosterone stimulates erythropoiesis — red blood cell production. Elevated hematocrit (polycythemia) is the most common adverse effect of TRT and increases the risk of clotting events if left unmonitored. Baseline hematocrit is essential for identifying men who are already at the higher end of normal before therapy begins and for setting a monitoring threshold. Most protocols flag hematocrit above 54 percent as a dose-adjustment trigger.
PSA (prostate-specific antigen)
For men over 40, a PSA is required before starting testosterone therapy. Testosterone does not cause prostate cancer, but it can accelerate growth of existing prostate tissue and potentially unmask subclinical disease. A baseline PSA establishes the starting value; significant PSA acceleration after starting TRT is a signal to pause therapy and investigate further.
Comprehensive metabolic panel (CMP)
Liver enzymes, kidney function, electrolytes, and glucose are checked at baseline. Testosterone is metabolized hepatically; while injectable and topical testosterone have much less hepatotoxic potential than oral methylated androgens, confirming normal liver function before starting therapy is standard practice. Blood glucose and metabolic markers also provide context for interpreting symptom changes during therapy.
Prolactin (when indicated)
Elevated prolactin suppresses LH and FSH production, causing secondary hypogonadism. When a man presents with low testosterone, low libido, and secondary gonadotropin values, checking prolactin rules out a prolactinoma. This is not required in every TRT evaluation, but it is standard when the clinical picture suggests a central cause.
TRT testing is not bureaucratic friction — it is the clinical foundation that makes the therapy safe and the dose right.
What the numbers mean in practice
Reference ranges vary by laboratory, but the commonly applied clinical threshold for total testosterone deficiency in adult men is below 300 ng/dL on two morning draws. Some guidelines and many practicing clinicians also use 350 ng/dL as a threshold when free testosterone is suppressed or symptoms are significant.
A number on its own does not determine whether TRT is appropriate. Clinicians integrate the lab values with the patient’s reported symptoms — fatigue, reduced libido, mood changes, loss of muscle mass, difficulty concentrating — and with the full hormonal picture including SHBG, LH, FSH, and estradiol. A man with a total testosterone of 280 ng/dL and no symptoms may not be a candidate. A man at 320 ng/dL with very high SHBG, low free testosterone, and significant symptoms may be. The clinical judgment matters.
How often do you need labs while on TRT?
TRT is not a set-and-forget prescription. Standard monitoring protocol calls for a follow-up panel at 3 months after starting therapy, again at 6 months, and then annually once levels are stable. Each follow-up panel typically includes total testosterone (drawn mid-cycle for injectables, at the expected trough), hematocrit, estradiol, and PSA.
Hematocrit monitoring is non-negotiable. Most protocols pause or reduce dosing if hematocrit rises above 54 percent. Therapeutic phlebotomy (blood donation) is sometimes used to manage persistently elevated values in men who respond strongly to therapy.
PSA monitoring continues annually for men over 40. A PSA doubling time of less than 12 months or a rise of more than 1.4 ng/mL above baseline within 12 months of starting TRT is a signal for urological referral.
What to expect from a clinician-supervised TRT evaluation
A thorough initial evaluation collects your symptom history, reviews any prior hormone testing, orders the baseline panel described above, and interprets results in the context of your health history and goals. The clinician confirms a qualifying diagnosis before writing a prescription and discusses the available formulations — injections, topical gels or creams, subcutaneous pellets — with their respective trade-offs.
Testosterone replacement therapy uses FDA-approved pharmaceutical-grade testosterone. For most men, generic testosterone cypionate via injection is the most cost-effective and consistently dosed option. Topical formulations offer convenience but require attention to transfer risk in households with children or female partners.
PepScribe connects patients with licensed clinicians for testosterone evaluation through a clinician-supervised consultation process. Labs are required as part of the intake, not as an afterthought.
Frequently asked questions about TRT testing
What lab tests are required before starting TRT?
Clinicians typically require two morning serum total testosterone draws (collected between 7 and 10 AM on separate days), a complete blood count (CBC), comprehensive metabolic panel (CMP), LH, FSH, SHBG, estradiol, PSA (for men over 40), and hematocrit. Some protocols also include free testosterone, prolactin, and thyroid panel depending on symptom picture.
Why does TRT testing require two testosterone draws?
Testosterone secretion is pulsatile and follows a circadian rhythm, peaking in the early morning. A single low reading can reflect normal daily variation rather than true deficiency. Two separate morning values below the reference range, along with clinical symptoms, are the standard threshold used by the Endocrine Society and most insurance payers to confirm hypogonadism before prescribing.
What testosterone level qualifies for TRT?
Most guidelines define deficiency as total testosterone below 300 ng/dL on two morning measurements, accompanied by signs and symptoms of low testosterone. Some clinicians use 350 ng/dL as a clinical threshold when free testosterone is also suppressed. The number alone does not determine treatment — symptoms and the full lab picture matter.
How often do you need labs while on TRT?
Standard monitoring includes a follow-up panel at 3 and 6 months after starting therapy, then annually if levels are stable. Hematocrit, PSA, and total testosterone are the most important values to track. Hematocrit in particular requires monitoring because testosterone raises red blood cell production, which can increase clotting risk if levels climb too high.
Can you start TRT without labs?
No responsible clinician will prescribe testosterone replacement without baseline bloodwork. Prescribing without labs bypasses the safety checks that identify polycythemia risk, underlying pituitary disorders, prostate concerns, and cardiovascular contraindications. Any service offering testosterone without prior lab results is operating outside standard of care.
What does SHBG have to do with TRT testing?
Sex hormone-binding globulin (SHBG) is the protein that binds testosterone in the bloodstream, making it unavailable to tissues. A man with total testosterone at the low end of normal but very high SHBG may have significantly reduced free (active) testosterone. Measuring SHBG and calculating free testosterone gives a fuller picture of androgen availability than total testosterone alone.